These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8430186)

  • 1. Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease.
    Ball WS; Nadel SN; Zimmerman RA; Byrd SE; Dietrich RB; Prenger EC; Drayer BP; Nelson MD; Morgan FW; Altman NR
    Radiology; 1993 Mar; 186(3):769-74. PubMed ID: 8430186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical safety and efficacy of gadoteridol: a study in 411 patients with suspected intracranial and spinal disease.
    Runge VM; Bradley WG; Brant-Zawadzki MN; Carvlin MJ; DeSimone DN; Dean BL; Dillon WP; Drayer BP; Flanders AE; Harms SE
    Radiology; 1991 Dec; 181(3):701-9. PubMed ID: 1947085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of gadoteridol for magnetic resonance imaging of the brain and spine.
    Runge VM; Bronen RA; Davis KR
    Invest Radiol; 1992 Aug; 27 Suppl 1():S22-32. PubMed ID: 1506150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III clinical studies with gadoteridol for the evaluation of neurologic pathology. A European perspective.
    Seiderer M
    Invest Radiol; 1992 Aug; 27 Suppl 1():S33-8. PubMed ID: 1506151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of gadoteridol for contrast-enhanced magnetic resonance imaging in children.
    Ball WS; Parker JR; Davis PC; Glasier CM; Morris MR
    Invest Radiol; 1992 Aug; 27 Suppl 1():S45-52. PubMed ID: 1506153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
    Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
    Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of gadoteridol for magnetic resonance imaging of extracranial head and neck pathology.
    Zoarski GH; Parker JR; Lufkin RB; Harnsberger HR; Rhoda CH
    Invest Radiol; 1992 Aug; 27 Suppl 1():S53-7. PubMed ID: 1506154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.
    Carvlin MJ; De Simone DN; Meeks MJ
    Invest Radiol; 1992 Aug; 27 Suppl 1():S16-21. PubMed ID: 1506148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine.
    Sze G; Brant-Zawadzki M; Haughton VM; Maravilla KR; McNamara MT; Kumar AJ; Aisen AM; Dreisbach JN; Bradley WG; Weinreb JC
    Radiology; 1991 Dec; 181(3):693-9. PubMed ID: 1947084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging of the central nervous system in children with a new nonionic gadolinium contrast agent--gadoteridol injection (ProHance).
    Byrd SE; Darling CF; Wilczynski MA
    J Natl Med Assoc; 1993 May; 85(5):361-6. PubMed ID: 8496990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of contrast enhancement in the pediatric spine at MR imaging with single- and triple-dose gadolinium.
    Tam JK; Bradley WG; Goergen SK; Chen DY; Pema PJ; Dubin MD; Teresi LM; Jordan JE
    Radiology; 1996 Jan; 198(1):273-8. PubMed ID: 8539393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
    Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
    Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spine--phase II-III clinical trial.
    Greco A; McNamara MT; Lanthiez P; Quay SC; Michelozzi G
    Radiology; 1990 Aug; 176(2):451-6. PubMed ID: 2195593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
    Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
    Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
    Svaland MG; Christensen T; Lundorf E
    Acta Radiol; 1994 Jul; 35(4):396-9. PubMed ID: 8011392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
    Peterson MS; Baron RL; Murakami T
    Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of neuroimaging with gadoversetamide injection in pediatric patients.
    Lowe LH; Kearns GL; Wible JH
    Curr Med Res Opin; 2006 Dec; 22(12):2515-24. PubMed ID: 17166334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging.
    Mathews VP; Caldemeyer KS; Lowe MJ; Greenspan SL; Weber DM; Ulmer JL
    Radiology; 1999 Apr; 211(1):257-63. PubMed ID: 10189481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter trial of gadoteridol, a nonionic gadolinium chelate, in patients with suspected head and neck pathology.
    Zoarski GH; Lufkin RB; Bradley WG; Flanders AE; Gale DR; Harms SE; Haughton VM; Joy SE; Kanal E; Rosa L
    AJNR Am J Neuroradiol; 1993; 14(4):955-61. PubMed ID: 8352170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: an animal study.
    Runge VM; Kirsch JE; Wells JW; Woolfolk CE
    AJR Am J Roentgenol; 1993 Mar; 160(3):593-600. PubMed ID: 8430562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.